Russell Investments Group Ltd. Buys 223,126 Shares of Baxter International Inc. $BAX

Russell Investments Group Ltd. lifted its position in shares of Baxter International Inc. (NYSE:BAX – Free Report) by 6.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,522,036 shares of the medical instruments supplier’s stock after purchasing an additional 223,126 shares during the quarter. Russell Investments Group Ltd. owned 0.68% of Baxter International worth $84,529,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the company. BlackRock Inc. purchased a new stake in shares of Baxter International during the second quarter worth about $1,744,874,000. Pzena Investment Management LLC acquired a new stake in shares of Baxter International in the 2nd quarter worth $1,392,098,000. Equity Investment Corp acquired a new stake in shares of Baxter International in the 2nd quarter worth $146,815,000. Bank of America Corp DE acquired a new stake in shares of Baxter International in the 2nd quarter worth $132,993,000. Finally, Bank of New York Mellon Corp purchased a new position in shares of Baxter International during the 2nd quarter worth $68,036,000. 90.19% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

BAX has been the topic of several recent research reports. Stifel Nicolaus boosted their price target on shares of Baxter International from $19.00 to $24.00 and gave the company a “hold” rating in a research report on Tuesday, July 28th. Wall Street Zen upgraded shares of Baxter International from a “hold” rating to a “buy” rating in a research report on Saturday, October 31st. UBS Group lifted their target price on shares of Baxter International from $19.00 to $25.00 and gave the stock a “hold” rating in a research note on Tuesday, July 28th. Jefferies Financial Group reiterated a “hold” rating and issued a $25.00 target price on shares of Baxter International in a report on Thursday, October 29th. Finally, Wolfe Research assumed coverage on shares of Baxter International in a report on Tuesday, October 20th. They issued a “peer perform” rating on the stock. One investment analyst has rated the stock with a Buy rating, ten have issued a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, Baxter International presently has an average rating of “Reduce” and a consensus target price of $23.27.

Check Out Our Latest Stock Analysis on BAX

Baxter International Trading Up 0.1%

Shares of NYSE BAX traded up $0.03 during mid-day trading on Friday, reaching $25.77. 4,491,214 shares of the company’s stock were exchanged, compared to its average volume of 7,506,119. The firm has a market capitalization of $13.33 billion, a price-to-earnings ratio of -18.28, a PEG ratio of 3.78 and a beta of 0.68. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.19 and a current ratio of 1.79. Baxter International Inc. has a 52-week low of $15.73 and a 52-week high of $30.00. The company’s 50-day moving average is $24.54 and its 200-day moving average is $21.67.

Baxter International (NYSE:BAX – Get Free Report) last announced its earnings results on Thursday, October 29th. The medical instruments supplier reported $0.58 earnings per share for the quarter, topping the consensus estimate of $0.52 by $0.06. The company had revenue of $2.98 billion during the quarter, compared to analyst estimates of $2.91 billion. Baxter International had a negative net margin of 6.23% and a positive return on equity of 16.23%. Baxter International’s revenue was up 5.0% compared to the same quarter last year. During the same quarter last year, the firm posted $0.69 earnings per share. Analysts expect that Baxter International Inc. will post 2.10 EPS for the current fiscal year.

Baxter International Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Friday, November 27th will be given a $0.01 dividend. The ex-dividend date of this dividend is Friday, November 27th. This represents a $0.04 dividend on an annualized basis and a yield of 0.2%. Baxter International’s payout ratio is presently -2.84%.

About Baxter International

(Free Report)

Baxter International is a global healthcare company that develops and supplies products used in hospitals, clinics and other care settings. Its offerings include intravenous solutions and administration sets, infusion pumps, medication-delivery systems, and products for surgical and hospital care. The company also provides patient-monitoring and connected-care technologies, including products associated with Hillrom, which Baxter acquired in 2021. Its products and services support healthcare professionals and patients in countries around the world.

Further Reading

Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc. (NYSE:BAX – Free Report).

Institutional Ownership by Quarter for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.